
    
      This is a multicenter, double-blind, randomized, parallel group study. The subjects who meet
      all of the inclusion criteria and none of the exclusion criteria will be randomized, and will
      orally receive either OPT-80 twice daily or vancomycin powder four times daily for 10 days. A
      follow-up investigation will be performed 28 (Â±3) days after the completion of study drug
      administration.
    
  